To investigate the involvement of transcriptional regulators in CRC progression, we assessed the role of NF-κB, a transcription factor known to be constitutively activated in various malignancies due to autocrine and paracrine signaling within the tumor microenvironment. The gene discussed is NFKB1; the disease is colorectal carcinoma.